
Sign up to save your podcasts
Or


Two studies in The Lancet Infectious Diseases describe how the spread of resistance to both dihydroartemisinin and piperaquine is compromising malaria therapy in South-East Asia
By The Lancet Infectious DiseasesTwo studies in The Lancet Infectious Diseases describe how the spread of resistance to both dihydroartemisinin and piperaquine is compromising malaria therapy in South-East Asia